Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

NCT00220727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified

Sponsor

Grifols Therapeutics LLC